AP
ARS Pharmaceuticals, Inc
🇺🇸XNAS.SPRYUnited StatesHealthcare
$7.92USDdown -0.11 (-1.37%)OpenDelayed2:27 PM
Price$7.92-0.11 (-1.37%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US82835W1080
- CUSIP
- 82835W108
Company
- Employees
- 195
- Headquarters
- San Diego, United States
- Website
- https://ars-pharma.com
- CEO
- Mr. Donn Casale
Market
- Shares outstanding
- 99.4M
- Market cap
- $786.43M
Key dates
- Next earnings
- Nov 9, 2026
Highlights
- Market cap
- $786.43M
- EPS LTM
- -$2.17calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -3.66calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $116.93M+4.08%up year on year
- Net income
- -$215.43M-348.66%down year on year
- Gross margin
- 73.89%-16.41%down year on year
- Free cash flow
- -$196.6M-268.3%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.